Glycostem to present at the business partnering event Advanced Therapy Showcase in Tokyo#1 on 21st January at 09.35 CET/17:35 GMT+9 with live streaming.
The Kempen X-over Selection connects a curated list of private European Biotechs with global institutional investors active in the crossover space.
Glycostem attends the 2nd Annual Cell & Gene Therapy Manufacturing conference virtually. Our CEO Troels Jordansen shares Glycostem world’s first off-the-shelf NK cell-based immunotherapy in the fight against cancer.
Glycostem participates the 7th Solebury Trout Private Company Showcase co-hosted by BMO and Davis Polk. Glycostem CEO Troels Jordansen presents virtually on Thursday 15th Oct 2020, with featured presentation and Q&A session.